These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 25168098)

  • 41. Clinical outcome following second-generation drug-eluting stent use for off-label versus on-label indications: insights from the two-year outcome of the TWENTE trial.
    Sen H; Lam MK; Tandjung K; Basalus MW; de Man FH; Louwerenburg JH; Stoel MG; van Houwelingen GK; Löwik MM; Linssen GC; Saïd SA; Nienhuis MB; Verhorst PM; van der Palen J; von Birgelen C
    EuroIntervention; 2014 Oct; 10(6):664-71. PubMed ID: 25330500
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Native coronary artery or bypass graft percutaneous coronary intervention in patients after previous coronary artery bypass surgery: A large nationwide analysis from the Netherlands Heart Registration.
    Beerkens FJ; Küçük IT; van Veelen A; de Lind van Wijngaarden RAF; Timmermans MJC; Mehran R; Dangas G; Klautz R; Henriques JPS; Claessen BEPM;
    Int J Cardiol; 2024 Jun; 405():131974. PubMed ID: 38493833
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Drug-eluting stenting of saphenous vein graft versus native coronary artery supplying the same myocardial perfusion territory: a pilot retrospective 3-year follow-up.
    Ho PC; Lee AC; Fortuna R
    J Invasive Cardiol; 2012 Oct; 24(10):516-20. PubMed ID: 23043035
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early beneficial effects of drug-eluting stents in vein grafts wane during long term follow-up: a case-control study.
    Pasceri V; Tarsia G; Niccoli G; Viceconte N; Porto I; Leone AM; Trani C; Speciale G; Lisanti P
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1112-7. PubMed ID: 22422701
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Meta-analysis of 14 trials comparing bypass grafting vs drug-eluting stents in diabetic patients with multivessel coronary artery disease.
    De Luca G; Schaffer A; Verdoia M; Suryapranata H
    Nutr Metab Cardiovasc Dis; 2014 Apr; 24(4):344-54. PubMed ID: 24373711
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative one-year effectiveness of percutaneous coronary intervention versus coronary artery bypass grafting in patients <75 versus ≥75 years with unprotected left main disease (from the CUSTOMIZE Registry).
    Capodanno D; Caggegi A; Capranzano P; Milino V; Chisari A; Mangiameli A; Monaco S; Barrano G; Di Salvo ME; Tamburino C
    Am J Cardiol; 2012 Nov; 110(10):1452-8. PubMed ID: 22853983
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Current clinical outcomes of percutaneous coronary intervention and coronary artery bypass grafting.
    Mack MJ; Prince SL; Herbert M; Brown PP; Katz M; Palmer G; Edgerton JR; Eichhorn E; Magee MJ; Dewey TM
    Ann Thorac Surg; 2008 Aug; 86(2):496-503; discussion 503. PubMed ID: 18640323
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative long-term efficacy and safety of drug-eluting stent versus coronary artery bypass grafting in ostial left main coronary artery disease: analysis of the MAIN-COMPARE registry.
    Lee SW; Kim SH; Kim SO; Han S; Kim YH; Park DW; Kang SJ; Lee CW; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2012 Aug; 80(2):206-12. PubMed ID: 22234884
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 4-year clinical outcomes and predictors of repeat revascularization in patients treated with new-generation drug-eluting stents: a report from the RESOLUTE All-Comers trial (A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention).
    Taniwaki M; Stefanini GG; Silber S; Richardt G; Vranckx P; Serruys PW; Buszman PE; Kelbaek H; Windecker S;
    J Am Coll Cardiol; 2014 Apr; 63(16):1617-25. PubMed ID: 24530680
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prolonged effectiveness of coronary artery bypass surgery versus drug-eluting stents in diabetics with multi-vessel disease: an updated systematic review and meta-analysis.
    Ariyaratne TV; Ademi Z; Yap CH; Billah B; Rosenfeldt F; Yan BP; Reid CM
    Int J Cardiol; 2014 Sep; 176(2):346-53. PubMed ID: 25127976
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term outcomes of three-vessel coronary artery disease after coronary revascularization by percutaneous coronary intervention using second-generation drug-eluting stents versus coronary artery bypass graft surgery.
    Hata R; Kubo S; Tsuneyoshi H; Shimamoto T; Kuwayama A; Ohya M; Shimada T; Miura K; Amano H; Otsuru S; Habara S; Tada T; Tanaka H; Fuku Y; Goto T; Komiya T; Kadota K
    Cardiovasc Interv Ther; 2020 Apr; 35(2):194-202. PubMed ID: 31292929
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of 5-year outcomes in patients with and without unprotected left main coronary artery disease after treatment with sirolimus-eluting stents: insights from the j-Cypher registry.
    Toyofuku M; Kimura T; Morimoto T; Hayashi Y; Shiode N; Nishikawa H; Nakao K; Shirota K; Kawai K; Hiasa Y; Kadota K; Nozaki Y; Isshiki T; Sone T; Mitsudo K;
    JACC Cardiovasc Interv; 2013 Jul; 6(7):654-63. PubMed ID: 23866178
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial.
    Kapur A; Hall RJ; Malik IS; Qureshi AC; Butts J; de Belder M; Baumbach A; Angelini G; de Belder A; Oldroyd KG; Flather M; Roughton M; Nihoyannopoulos P; Bagger JP; Morgan K; Beatt KJ
    J Am Coll Cardiol; 2010 Feb; 55(5):432-40. PubMed ID: 20117456
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incidence and outcome of surgical procedures after coronary artery bypass grafting compared with those after percutaneous coronary intervention: a report from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2.
    Tokushige A; Shiomi H; Morimoto T; Ono K; Furukawa Y; Nakagawa Y; Kadota K; Ando K; Shizuta S; Tada T; Tazaki J; Kato Y; Hayano M; Abe M; Hamasaki S; Ohishi M; Nakashima H; Mitsudo K; Nobuyoshi M; Kita T; Imoto Y; Sakata R; Okabayashi H; Hanyu M; Shimamoto M; Nishiwaki N; Komiya T; Kimura T;
    Circ Cardiovasc Interv; 2014 Aug; 7(4):482-91. PubMed ID: 25074253
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry.
    Abdel-Wahab M; Nienaber CA; Mostafa AE; Sabin G; Tebbe U; Hochadel M; Senges J; Akin I; Kuck KH; Hamm C; Richardt G;
    EuroIntervention; 2011 Jun; 7(2):201-8. PubMed ID: 21646062
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PCI versus CABG for multivessel coronary disease in diabetics.
    Tarantini G; Ramondo A; Napodano M; Favaretto E; Gardin A; Bilato C; Nesseris G; Tarzia V; Cademartiri F; Gerosa G; Iliceto S
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):50-8. PubMed ID: 19089938
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term trends of treatment effect of stenting or bypass surgery in patients with ostial or shaft left main coronary artery disease.
    Yoon YH; Lee PH; Ahn JM; Kang DY; Park H; Kwon O; Lee K; Lee SW; Park DW; Park SJ;
    Catheter Cardiovasc Interv; 2019 Sep; 94(3):315-322. PubMed ID: 30724018
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The impact of previous revascularization on clinical outcomes in patients undergoing primary percutaneous coronary intervention.
    Bench TJ; Parikh PB; Jeremias A; Brener SJ; Naidu SS; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
    J Invasive Cardiol; 2013 Apr; 25(4):166-9. PubMed ID: 23549488
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of diabetes mellitus on long-term outcomes of patients with unprotected left main coronary artery disease treated with either drug-eluting stents or coronary artery bypass grafting.
    Yu X; He J; Luo Y; Yuan F; Song X; Gao Y; Li Q; Huang F; Gu C; Lv S; Chen F
    Int Heart J; 2015; 56(1):43-8. PubMed ID: 25742942
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Validity of SYNTAX score II for risk stratification of percutaneous coronary interventions: A patient-level pooled analysis of 5,433 patients enrolled in contemporary coronary stent trials.
    Campos CM; Garcia-Garcia HM; van Klaveren D; Ishibashi Y; Cho YK; Valgimigli M; Räber L; Jonker H; Onuma Y; Farooq V; Garg S; Windecker S; Morel MA; Steyerberg EW; Serruys PW
    Int J Cardiol; 2015; 187():111-5. PubMed ID: 25828327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.